The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Viscosupplementation Global Market Report 2024, the viscosupplementation market is expected to show significant growth in the forecast period.

The viscosupplementation market is witnessing exponential growth, driven by various factors including the rise in osteoarthritis cases, increased awareness, and patient preference. Here’s a closer look at the dynamics propelling this growth:

• Market Size and Growth Trends:
  • The market size has surged from $3.74 billion in 2023 to $4.15 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%.
  • Projected to reach $6.19 billion in 2028 with a CAGR of 10.5%.
• Contributing Factors:
  • Aging population
  • Rising obesity rates
  • Enhanced insurance coverage
  • Growing awareness
  • Patient preference
  • Increased osteoarthritis cases

View More On The Viscosupplementation Market Report 2024 – https://www.thebusinessresearchcompany.com/report/viscosupplementation-global-market-report

Technological Strides Transforming The Viscosupplementation Market

Technological advancements play a pivotal role in shaping the viscosupplementation landscape. Companies are leveraging new technologies to stay competitive and enhance treatment options:

• Innovative Solutions:
  • Seikagaku Corporation introduces HyLink®, a novel viscosupplement with cross-linking technology, addressing knee osteoarthritis.
  • Cross-linking technology ensures prolonged efficacy of the treatment.

Avanos Medical Inc.’s Acquisition Of Orthogenrx Inc. Bolsters Chronic Pain Portfolio And Global Healthcare Relations

Strategic acquisitions are reshaping the viscosupplementation market, enabling companies to expand their offerings and strengthen global relations:

• Acquisition Details:
  • Avanos Medical Inc. acquires OrthogenRx Inc. for $160 million in December 2021.
  • Broadens chronic pain product portfolio.
  • Strengthens global healthcare provider relationships.

Market Segmentation

Understanding the diverse segments within the viscosupplementation market provides insights into its varied applications and end-users:

• Segmentation Categories:
  1. Type:
     • Single Injection Viscosupplementation
     • Three Injection Viscosupplementation
     • Five Injection Viscosupplementation
  2. Source:
     • Avian Origin
     • Non-Avian Origin
  3. Hyaluronic Acids:
     • Standard Hyaluronic Acid
     • Stabilized Hyaluronic Acid
  4. Application:
     • Knee Osteoarthritis
     • Hip Osteoarthritis
     • Hand Osteoarthritis
  5. End-User:
     • Hospitals
     • Ambulatory Surgical Centers
     • Other End-Users

Regional Insights: North America Leads the Way

North America emerges as a frontrunner in the viscosupplementation market, showcasing significant growth and dominance:

• Market Dominance:
  • North America leads the viscosupplementation market as of 2023.
  • Continues to witness substantial growth owing to advanced healthcare infrastructure and rising osteoarthritis cases.

In conclusion, the viscosupplementation market’s rapid expansion is underpinned by a confluence of factors, including technological advancements, strategic acquisitions, and a growing understanding of osteoarthritis. As the market continues to evolve, companies must remain agile to capitalize on emerging opportunities and address evolving patient needs.

Request A Sample Of The Global Viscosupplementation Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=9836&type=smp